Skip to main content
Log in

Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: A collaborative controlled study

  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Abstract

Doxepin was compared to the combination of amitriptyline-perphenazine in a double-blind controlled study conducted with 100 clinic, general practice, and private psychiatric practice outpatients diagnosed as suffering from a mixed anxiety-depressive reaction. The relatively few statistically significant differences found in the study indicated amitriptyline-perphenazine to be more effective than doxepin (main drug effects), general practice patients to improve the most and private psychiatric patients the least (main population effects), and clinic patients to respond better to doxepin, while general practice and private psychiatric patients improved most with the drug combination (drug×population interaction effects).

Amitriptyline-perphenazine was found to produce more improvement in high and doxepin in low depressed patients, and doxepin was observed to be more effective in lower than in higher social class patients. Patients on doxepin tended to report more side effects, but to drop out less frequently than patients on the drug combination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beaubien, J., Ban, T. A., Lehmann, H. E., Jarrold, L.: Doxepin in the treatment of psychoneurotic outpatients. Curr. ther. Res. 12, 192–194 (1970).

    Google Scholar 

  • DeSilverio, R. V., Rickels, K., Weise, C. C., Clark, E. L., Hutchison, J.: Perphenazine-amitriptyline in neurotic depressed outpatients: A controlled collaborative study. Amer. J. Psychiat. 127, 322–328 (1970).

    Google Scholar 

  • Goldstein, B. J., Pinosky, D. G.: Clinical evaluation of doxepin in anxious depressed outpatients. Curr. ther. Res. 11, 169–177 (1969).

    Google Scholar 

  • Hackett, E., Gold, R. L., Kline, N. S., Winick, L.: Controlled evaluation of psychotropic drugs in a private psychiatric practice: Doxepin vs. amitriptyline (Elavil). Psychosomatics 8, 162–165 (1967).

    Google Scholar 

  • Krakowski, A. J.: Activity study of doxepin: A new antidepressant. Psychosomatics. 9, 89–95 (1968).

    Google Scholar 

  • Lipman, R. S., Covi, L., Rickels, K.: Uhlenhuth, E. H., Lazar, R.: Selected measures of change in outpatient drug evaluation. In: D. H. Efron, J. O. Cole, J. Levine and J. R. Wittenborn (eds.): Psychopharmacology: A Review of Progress, 1957–1967. Public Health Service Publication No. 1836, pp. 249–254 (1968).

  • Pitts, N. E.: The clinical evaluation of doxepin—A new psychotherapeutic agent. Psychosomatics 10, 164–171 (1969).

    Google Scholar 

  • Rickels, K., Howard, K.: The physician questionnaire: A useful tool in psychiatric drug research. Psychopharmacologia (Berl.) 17, 338–344 (1970).

    Google Scholar 

  • —, Jenkins, B. W., Zamostien, B., Raab, E., Kanther, M.: Pharmacotherapy in neurotic depression. J. nerv. ment. Dis. 145, 475–485 (1968).

    Google Scholar 

  • —, Perloff, M., Stepansky, W., Dion, H. S., Case, W. G., Sapra, R. K.: Doxepin and diazepam in general practice and hospital clinic neurotic patients: A collaborative controlled study. Psychopharmacologia (Berl.) 15, 265–279 (1969).

    Google Scholar 

  • Simeon, J., Spero, M., Nikolovski, O. T., Fink, M.: A comparison of doxepin and chlordiazepoxide in the therapy of anxiety. Curr. ther. Res. 12, 201–212 (1970).

    Google Scholar 

  • Uhlenhuth, E. H., Duncan, D. B., Park, L. C.: Some non-pharmacologic modifiers of the response to imipramine in depressed, psychoneurotic outpatients: A confirmatory study. In: P. R. A. May and J. R. Wittenborn (eds.): Psychotropic Drug Response: Advances in Prediction, pp. 155–197. Springfield, Ill.: Ch. C. Thomas 1969.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This research was supported in part by USPHS Grants MH-08957-8. All medications were provided by Pfizer Laboratories.

Dr. Rickels is Professor of Psychiatry, University of Pennsylvania, and Director of the Psychopharmacology Unit, Philadelphia General Hospital. Drs. Hutchison, Weise, Csanalosi, Chung, and Case are either members of our Private Practice Research Group or clinic psychiatrists.

The authors wish to thank Drs. Stanford E. Bazilian, Robert V. DeSilverio, Jorge A. Pereira-Ogan, and Milton M. Perloff; Mr. Peter Hesbacher and Misses Reita Brandt, Ellen Fisher, and Joanne Johnson for their participation in various phases of this project.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rickels, K., Hutchison, J.C., Weise, C.C. et al. Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: A collaborative controlled study. Psychopharmacologia 23, 305–318 (1972). https://doi.org/10.1007/BF00406734

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00406734

Key words

Navigation